The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Sep. 08, 2022
Applicant:
Bausch + Lomb Ireland Limited, Dublin, IE;
Inventors:
Joseph Paul Bullock, Fort Worth, TX (US);
Chinmay Maheshwari, Mason, OH (US);
Quintus Medley, Wellesley, MA (US);
Muneto Mogi, Waltham, MA (US);
Michela Montecchi-Palmer, Fort Worth, TX (US);
Kalliopi Stasi, Watertown, MA (US);
Assignee:
Bausch + Lomb Ireland Limited, Dublin, IE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/02 (2005.12); A61K 9/48 (2005.12); A61K 31/517 (2005.12); A61K 47/10 (2016.12); A61K 47/26 (2005.12); A61K 47/38 (2005.12); A61K 9/00 (2005.12);
U.S. Cl.
CPC ...
A61K 31/517 (2012.12); A61K 47/02 (2012.12); A61K 47/10 (2012.12); A61K 47/26 (2012.12); A61K 47/38 (2012.12); A61K 9/0048 (2012.12);
Abstract
The present invention provides formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile (compound I) and methods for treating ocular surface pain by administering such formulations. The present invention also provides methods for treating dry eye disease and ocular hyperemia by administering formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile.